Why is "American Academy of Dermatology" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-11 00:34:46
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
The American Academy of Dermatology (AAD) is a non-profit professional organization of dermatologists in the United States and Canada, based in Rosemont, Illinois, near Chicago. It was founded in 1938 and has more than 21,000 members. The academy grants fellowships and associate memberships, as well as fellowships for nonresidents of the United States or Canada. Since 1979, the AAD also publishes a monthly medical journal, the Journal of the American Academy of Dermatology.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting - PR Newswire
-
Friend and foe: The dual role of sunlight on overall health | AAD 2026 - Managed Healthcare Executive
-
AAD: What’s in Derms’ Bags (Part 1) - NewBeauty
-
Kenvue unleashes science-driven skincare offensive at American Academy of Dermatology meet - Indian Pharma Post
-
Emerging Therapies, Innovations Highlight the Evolving Dermatology Treatment Landscape - ajmc.com
-
Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138 - Yahoo Finance
-
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting - Investing News Network
-
InflaRx Highlights Clinical Activity of Vilobelimab in - GlobeNewswire
-
Hallux Poster Exhibit Abstract on Dermatophytoma Treatment at 2026 American Academy of Dermatology Annual - einnews.com
-
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting - ChartMill
-
American Academy of Dermatology Installs New Officers, Board Members - PR Newswire
-
MIPS, it missed the mark. But DataDerm “is exactly what we need,” says Marta J. Van Beek, M.D., M.P.H. | AAD 2026 - Managed Healthcare Executive
-
PCP Support, Community Outreach Help Close Rural Dermatology Access Gaps - ajmc.com
-
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Yahoo Finance
-
Murad Alam, MD, MSCI, MBA, FAAD, assumes presidency of the American Academy of Dermatology - PR Newswire
-
Dermatology experts highlight climate risks and healthcare access gaps | AAD 2026 - Managed Healthcare Executive
-
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity - Yahoo Finance
-
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting - PR Newswire
-
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement - TMX Newsfile
-
Experimental eczema pill cut disease severity 77% in 12-week trial - Stock Titan
-
American Academy of Dermatology Association Statement on FDA withdrawing Proposed Sunlamp Regulation | Newswise - Newswise
-
The Future of Skin Aging May Be Found in The Kitchen: 2026 American Academy of Dermatology Annual Meeting to Highlight Latest Advancements in Skin, Hair, and Nails - TMX Newsfile
-
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting - BioSpace
-
Nearly half of infants saw eczema itch ease in 10 minutes - Stock Titan
-
Journal of the American Academy of Dermatology - ScienceDirect.com
-
Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting - The Manila Times
-
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting - ChartMill
-
New Clinical Frontiers for Acclaro's UltraClear® 2910 nm Fiber Laser Revealed by Leading Experts at the American Academy of Dermatology Annual Meeting - PR Newswire
-
Journal of the American Academy of Dermatology | Vol 94, Issue 1, Pages A1-A36, e1-e70, 1-420 (January 2026) - ScienceDirect.com
-
Journal of the American Academy of Dermatology - ScienceDirect.com
-
Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting - ChartMill
-
Joint statement from the American Academy of Dermatology Association and the New York State Society of Dermatology and Dermatologic Surgery on New York City Council medspa investigation - PR Newswire
-
Biogen to Present New Late-Breaking Litifilimab Phase 2 - GlobeNewswire
-
A skin cancer study with 65% response sends Phio to a late-breaker stage - Stock Titan
-
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting - The Manila Times
-
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting - Business Wire
-
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting - The Manila Times
-
Incyte presented the latest positive 54-week data on its investigational drug Povorcitinib for the treatment of hidradenitis suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting. - Bitget
-
Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - BioSpace
-
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Via TT
-
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting - Yahoo Finance
-
Journal of the American Academy of Dermatology | Vol 93, Issue 2, Pages A1-A40, e47-e100, 329-584 (August 2025) - ScienceDirect.com
-
Aclaris Therapeutics Announces Poster on Results from Phase - GlobeNewswire
-
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting - itemonline.com
-
The future of skin aging may be found in the kitchen: 2026 American Academy of Dermatology Annual Meeting to highlight latest advancements in skin, hair, and nails - StreetInsider
-
New eczema trial results from Aclaris will debut at dermatology meeting - Stock Titan
-
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting - Yahoo Finance
-
American Academy of Dermatology Association Statement on FDA Proposal for New Sunscreen Ingredient | Newswise - Newswise
-
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting - barchart.com
-
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting - Sahm
-
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Bitget
-
New eczema treatment data in infants and kids set for 2026 AAD - Stock Titan
-
Eirion Therapeutics to Present at the 2025 American Academy of Dermatology Innovation Academy Meeting - PR Newswire
-
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Sahm
-
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology Annual Meeting - Investing News Network
-
Bonsai Health Announces Strategic Partnership with the American Academy of Dermatology to Advance AI-Powered Practice Automation - Yahoo Finance
-
Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026 - The Manila Times
-
Experimental oral psoriasis drug’s Phase 3 results to debut at skin conference - Stock Titan
-
Beneath the Surface: How to get involved in the American Academy of Dermatology - Healio
-
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewswire
-
ICYMI: Highlights From AAD 2025 - ajmc.com
-
Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting - Bitget
-
St. Francis Hosting Free Skin Cancer Screening-March 28 - Midwest Medical Edition
-
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting - STT Info
-
Severe eczema drug from Connect Biopharma lands late-breaking AAD slot - Stock Titan
-
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting - The Manila Times
-
**Key Clinical Data to Be Revealed Soon** Biopharmaceutical company Alumis Inc. announced that the phase III clinical trial data of its lead candidate drug Envudeucitinib for the treatment of moderate-to-severe plaque psoriasis has been selected for the "Lat - Bitget
-
Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting - The Manila Times
-
Organon & Co. (OGN) Announces American Academy of Dermatology’s Strong Recommendation for VTAMA Cream - Yahoo Finance
-
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting - The Manila Times
-
AAD Statement on the FDA Safety Briefing About Radiofrequency Microneedling Risks | Newswise - Newswise
-
AAD Updates AD Guidelines With Four New Treatment Picks - Medscape
-
Journal of the American Academy of Dermatology | Vol 92, Issue 1, Pages A1-A36, e1-e34, 1-212 (January 2025) - ScienceDirect.com
-
Journal of the American Academy of Dermatology | Vol 90, Issue 1, Pages A1-A58, e1-e42, 1-222 (January 2024) - ScienceDirect.com
-
Journal of the American Academy of Dermatology | Vol 90, Issue 5, Pages A1-A42, e157-e190, 885-1122 (May 2024) - ScienceDirect.com
-
American Academy of Dermatology Upholds Diversity Policies in Face of Anti-DEI Proposal - Dermatology Times
-
Journal of the American Academy of Dermatology - ScienceDirect.com
-
Journal of the American Academy of Dermatology | Vol 92, Issue 4, Pages A1-A28, e89-e126, 677-968 (April 2025) - ScienceDirect.com
-
Journal of the American Academy of Dermatology | Vol 91, Issue 2, Pages A1-A22, e19-e38, 207-408 (August 2024) - ScienceDirect.com
-
Journal of the American Academy of Dermatology | Vol 90, Issue 3, Pages A1-A60, e87-e112, 453-680 (March 2024) - ScienceDirect.com
-
The Estée Lauder Companies Shares New Findings at the American Academy of Dermatology - elcompanies.com
-
UAB dermatology chair honored with 2025 American Academy of Dermatology Gold Medal Award - The University of Alabama at Birmingham
-
Journal of the American Academy of Dermatology | Vol 88, Issue 3, Pages A1-A58, e113-e156, 521-750 (March 2023) - ScienceDirect.com
-
ELC Brands at the American Academy of Dermatology Annual Conference - elcompanies.com
-
American Academy of Dermatology Association Statement on Physician Assistant Name Change | Newswise - Newswise
-
AAD Survey: Americans Misunderstand Sun Protection - Dermatology Times
-
American Academy of Dermatology publishes updated care guidelines for acne - Healio
-
Miller School Faculty Become President and Vice President of the American Academy of Dermatology - University of Miami
-
Journal of the American Academy of Dermatology | Vol 85, Issue 2, Pages A1-A44, e63-e135, 287-538 (August 2021) - ScienceDirect.com
-
PA Consulting partners with American Academy of Dermatology on data platform - Consulting.us
-
American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables | Newswise - Newswise
-
American Academy of Dermatology Reveals New Acne Vulgaris Guidelines - HCPLive
-
ICYMI: Highlights From the 2022 American Academy of Dermatology Meeting - ajmc.com
-
Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting - emjreviews.com
-
American Academy of Dermatology Elects New Officers, Board Members | Newswise - Newswise
-
American Academy of Dermatology names Brett King ‘Patient Care Hero’ - YaleNews
-
Advances in Dermatologic Research and Treatment: A Year in Review from the 2025 AAD Annual Meeting - emjreviews.com
-
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555 - PR Newswire
-
Journal of the American Academy of Dermatology | Vol 88, Issue 1, Pages A1-A58, e1-e71, 1-270 (January 2023) - ScienceDirect.com
-
Susan C. Taylor, MD, FAAD, Assumes Presidency of the American Academy of Dermatology | Newswise - Newswise
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.